Since it was observed that the increase of COX-2 activity amongst colorectal cancer patients is associated with greater progression of carcinogenesis, it is suggested that COX-2 expression might act as a prognostic factor in some aspects [98]. This evidence concerns the gene PTGS2 and colorectal cancer.